Skip Nav Destination
Issues
1 October 2009
-
Cover Image
Cover Image
In this first preclinical study, synthetic polymeric vectors based on pseudodendritic oligoamines were used for tumor-specific delivery of the sodium iodide symporter (NIS) gene after systemic delivery, resulting in a significant therapeutic effect of radioiodine in a neuroblastoma mouse model. The figure shows immunofluorescence analysis using a Ki67-specific antibody (green) and an antibody against CD31 (red, labeling blood vessels) revealing high proliferation and blood vessel density in control tumors in contrast to NIS-transduced tumors after radioiodine treatment. For further details, please see Klutz and coworkers on page 6079 in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
CCR Translations
Statistics in Clinical Cancer Research
Molecular Pathways
Human Cancer Biology
Down-regulation of ZIP4 by RNA Interference Inhibits Pancreatic Cancer Growth and Increases the Survival of Nude Mice with Pancreatic Cancer Xenografts
Min Li; Yuqing Zhang; Uddalak Bharadwaj; Qihui (Jim) Zhai; Charlotte H. Ahern; William E. Fisher; F. Charles Brunicardi; Craig D. Logsdon; Changyi Chen; Qizhi Yao
Proinflammatory Mediators Upregulate Snail in Head and Neck Squamous Cell Carcinoma
Maie A. St. John; Mariam Dohadwala; Jie Luo; Guanyu Wang; Gina Lee; Hubert Shih; Eileen Heinrich; Kostantyn Krysan; Tonya Walser; Saswati Hazra; Li Zhu; Chi Lai; Elliot Abemayor; Michael Fishbein; David A. Elashoff; Sherven Sharma; Steven M. Dubinett
Cancer Therapy: Preclinical
Vasoactivity of AG014699, a Clinically Active Small Molecule Inhibitor of Poly(ADP-ribose) Polymerase: a Contributory Factor to Chemopotentiation In vivo?
Majid Ali; Brian A. Telfer; Cian McCrudden; Martin O'Rourke; Huw D. Thomas; Marzieh Kamjoo; Suzanne Kyle; Tracy Robson; Chris Shaw; David G. Hirst; Nicola J. Curtin; Kaye J. Williams
Antiglioma Immunological Memory in Response to Conditional Cytotoxic/Immune-Stimulatory Gene Therapy: Humoral and Cellular Immunity Lead to Tumor Regression
A.K.M. Ghulam Muhammad; Marianela Candolfi; Gwendalyn D. King; Kader Yagiz; David Foulad; Yohei Mineharu; Kurt M. Kroeger; Katherine A. Treuer; W. Stephen Nichols; Nicholas S. Sanderson; Jieping Yang; Maksim Khayznikov; Nico Van Rooijen; Pedro R. Lowenstein; Maria G. Castro
Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks
Diane Palmieri; Paul R. Lockman; Fancy C. Thomas; Emily Hua; Jeanne Herring; Elizabeth Hargrave; Matthew Johnson; Natasha Flores; Yongzhen Qian; Eleazar Vega-Valle; Kunal S. Taskar; Vinay Rudraraju; Rajendar K. Mittapalli; Julie A. Gaasch; Kaci A. Bohn; Helen R. Thorsheim; David J. Liewehr; Sean Davis; John F. Reilly; Robert Walker; Julie L. Bronder; Lionel Feigenbaum; Seth M. Steinberg; Kevin Camphausen; Paul S. Meltzer; Victoria M. Richon; Quentin R. Smith; Patricia S. Steeg
Lymph Node–Targeted Immunotherapy Mediates Potent Immunity Resulting in Regression of Isolated or Metastatic Human Papillomavirus–Transformed Tumors
Kent A. Smith; Brenna L. Meisenburg; Victor L. Tam; Robb R. Pagarigan; Raymond Wong; Diljeet K. Joea; Liz Lantzy; Mayra A. Carrillo; Todd M. Gross; Uriel M. Malyankar; Chih-Sheng Chiang; Diane M. Da Silva; Thomas M. Kündig; W. Martin Kast; Zhiyong Qiu; Adrian Bot
Imaging, Diagnosis, Prognosis
MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival
Ewy A. Mathé; Giang Huong Nguyen; Elise D. Bowman; Yiqiang Zhao; Anuradha Budhu; Aaron J. Schetter; Rosemary Braun; Mark Reimers; Kensuke Kumamoto; Duncan Hughes; Nasser K. Altorki; Alan G. Casson; Chang-Gong Liu; Xin Wei Wang; Nozomu Yanaihara; Nobutoshi Hagiwara; Andrew J. Dannenberg; Masao Miyashita; Carlo M. Croce; Curtis C. Harris
Cancer Therapy: Clinical
A Phase I Dose-Finding Study of 5-Azacytidine in Combination with Sodium Phenylbutyrate in Patients with Refractory Solid Tumors
Jianqing Lin; Jill Gilbert; Michelle A. Rudek; James A. Zwiebel; Steve Gore; Anchalee Jiemjit; Ming Zhao; Sharyn D. Baker; Richard F. Ambinder; James G. Herman; Ross C. Donehower; Michael A. Carducci
Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the Treatment
Evangelia Razis; Panayotis Selviaridis; Stephanos Labropoulos; Jeremy L. Norris; Mei-Jun Zhu; David D. Song; Thea Kalebic; Michael Torrens; Anna Kalogera-Fountzila; George Karkavelas; Sofia Karanastasi; Jonathan A. Fletcher; George Fountzilas
Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma
Antoni Ribas; Begoña Comin-Anduix; Bartosz Chmielowski; Jason Jalil; Pilar de la Rocha; Tara A. McCannel; Maria Teresa Ochoa; Elizabeth Seja; Arturo Villanueva; Denise K. Oseguera; Bradley R. Straatsma; Alistair J. Cochran; John A. Glaspy; Liu Hui; Francesco M. Marincola; Ena Wang; James S. Economou; Jesus Gomez-Navarro
A Phase I Study of Sunitinib plus Bevacizumab in Advanced Solid Tumors
Brian I. Rini; Jorge A. Garcia; Matthew M. Cooney; Paul Elson; Allison Tyler; Kristi Beatty; Joseph Bokar; Tarek Mekhail; R.M. Bukowski; G. Thomas Budd; Pierre Triozzi; Ernest Borden; Percy Ivy; Helen X. Chen; Afshin Dowlati; Robert Dreicer
Susceptibility and Prevention
ΔNp63 Overexpression, Alone and in Combination with Other Biomarkers, Predicts the Development of Oral Cancer in Patients with Leukoplakia
Pierre Saintigny; Adel K. El-Naggar; Vali Papadimitrakopoulou; Hening Ren; You-Hong Fan; Lei Feng; J. Jack Lee; Edward S. Kim; Waun Ki Hong; Scott M. Lippman; Li Mao
Advertisement